Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Obes Surg ; 33(4): 1300-1303, 2023 04.
Article in English | MEDLINE | ID: covidwho-2291713

ABSTRACT

Inadequate access to public bariatric surgical services has favoured the growth of bariatric tourism. This study analysed data extracted from bariatric surgical centres that care for patients travelling from abroad. The research highlights apparent deficits in accreditation, communication, perioperative care, and travel health advice. An international registry of accredited bariatric tourism providers and patient education may be indicated.


Subject(s)
Bariatric Surgery , Medical Tourism , Obesity, Morbid , Humans , Tourism , Obesity, Morbid/surgery , Travel
2.
J Travel Med ; 28(8)2021 Dec 29.
Article in English | MEDLINE | ID: covidwho-2189287

Subject(s)
Computer Security , Humans
3.
Health Policy Technol ; 11(3): 100661, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-2007729
4.
Curr Infect Dis Rep ; 24(10): 129-145, 2022.
Article in English | MEDLINE | ID: covidwho-1982332

ABSTRACT

Purpose of Review: This review critically considers the impact of the COVID-19 pandemic on global travel and the practice of travel medicine, highlights key innovations that have facilitated the resumption of travel, and anticipates how travel medicine providers should prepare for the future of international travel. Recent Findings: Since asymptomatic transmission of the virus was first recognized in March 2020, extensive efforts have been made to characterize the pattern and dynamics of SARS-CoV-2 transmission aboard commercial aircraft, cruise ships, rail and bus transport, and in mass gatherings and quarantine facilities. Despite the negative impact of further waves of COVID-19 driven by the more transmissible Omicron variant, rapid increases of international tourist arrivals are occurring and modeling anticipates further growth. Mitigation of spread requires an integrated approach that combines masking, physical distancing, improving ventilation, testing, and quarantine. Vaccines and therapeutics have played a significant role in reopening society and accelerating the resumption of travel and further therapeutic innovation is likely. Summary: COVID-19 is likely to persist as an endemic infection, and surveillance will assume an even more important role. The pandemic has provided an impetus to advance technology for telemedicine, to adopt mobile devices and GPS in contact tracing, and to apply digital applications in research. The future of travel medicine should continue to harness these novel platforms in the clinical, research, and educational arenas.

5.
Am J Trop Med Hyg ; 2022 Jul 05.
Article in English | MEDLINE | ID: covidwho-1964294

ABSTRACT

Prior to the COVID-19 pandemic, there was a rapid increase in international travel. Travel medicine is a branch of preventive medicine focusing on risk assessment pre-travel, during travel and post-travel with the aim of promoting health and preventing adverse health outcomes. Travel medicine specialists inform travelers about potential health risks and mitigate infectious disease risks such as travelers' diarrhea, yellow fever, and malaria. Travel medicine topics were popular in the American Society of Tropical Medicine and Hygiene conferences between 2016 and 2020, and now comprise approximately 2% of all presentations. Most topics related to the post-travel assessment (44%), followed by diseases contracted during travel (24%), and pre-travel assessment and consultation (23%). Our analysis of the 10 sub-domains of travel medicine issues found that malaria (26%) and immunization (12%) were represented to the greatest extent. We anticipate that both travel and tropical medicine fields will regain their popularity after recovery from the pandemic.

6.
J Travel Med ; 28(8)2021 12 29.
Article in English | MEDLINE | ID: covidwho-1931857

Subject(s)
Social Media , Humans , Tourism , Travel
9.
J Public Health (Oxf) ; 43(1): e135-e136, 2021 04 12.
Article in English | MEDLINE | ID: covidwho-694300

ABSTRACT

As countries emerge from pandemic lockdown, many countries are relaxing international travel restrictions. Commercially available serologic tests for anti-SARS-CoV-2 antibodies are being performed. The concept of an 'immunity passport' has gained popularity, whereby evidence of SARS-CoV-2 antibody production would signal immunity to reinfection. For an immunity certificate to be validated for travel purposes, it should meet certain criteria. The introduction of such certificates faces multiple challenges. While there may be a future role for immunity passports in limited circumstances in the event that a protective vaccine becomes freely available, for now at least the risks of such an approach outweigh the perceived benefits.


Subject(s)
COVID-19/immunology , Social Control, Formal , Travel , Antibodies, Viral/blood , Communicable Disease Control/methods , Humans , Public Health , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL